Open access peer-reviewed Edited Volume

Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer

Michael Friedrich

HELIOS Klinikum Krefeld

Director of the HELIOS Klinikum Krefeld, a highly active academic researcher with an h index of 25, was previously affiliated with the University of Tübingen and the University of Aachen. Dr. Friedrich is a member of the ISSVD, ESGO, IGCS, ESMO, EUSOMA, ASCO, DGS, AGO, and the Society of Reconstructive Surgery in Gynecology (AWO-Gyn).

Covering

Molecular Profile BRCA Mutation Parp Inhibition Antiangiogenesis Checkpoint Inhibition Antihormonal Treatment Intraperitoneal Chemotherapy HIPEC Primary Debulking Surgery Interval Debulking Surgery Recurrent Ovarian Cancer Targeted Treatment

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Recent Advances, New Perspectives, and Applications in the Treatment of Ovarian Cancer should present a review of the significant advances in tumor biology and the treatment of ovarian cancer. Ovarian cancer is a heterogeneous disease with multiple distinct molecular and clinical subtypes.

In the first part of this book, the molecular profiles especially of the high-grade ovarian cancer will be described, and especially the clinical implications will be discussed.

The second part of the book will focus on the role of cytoreductive surgery, especially concerning the significant shift from primary cytoreductive surgery to neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer knowing that optimal debulking surgery with R0-resection remains the gold standard. In this context, the current data and recommendations for the use of HIPEC will be discussed.

Last but not least, the book will focus on systemic treatment beginning with chemotherapy like neoadjuvant strategies and ending with targeted treatment like PARP-inhibition and new aspects to immunobiological therapies.

Publishing process

Book initiated and editor appointed

Date completed: March 9th 2022

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Register here

Approved chapters written in full and submitted

Deadline for full chapters: July 10th 2022

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: September 28th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: November 27th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Michael Friedrich

HELIOS Klinikum Krefeld

Dr. Friedrich is the Director of the Department of Obstetrics and Gynecology of the Academic Teaching Hospital Krefeld. He is the author of more than 150 publications, mainly original contributions in peer-reviewed journals concerning gynecological malignancies and breast cancer as well as vitamin d metabolism. His main field of research activities is dealing with vitamin d metabolism in gynecological malignancies and in breast cancer. Another field of expertise is the interaction of DNA-mismatch repair and resistance to chemotherapy in gynecological malignancies. Further main points are the interstitial brachytherapy for recurrences of cervical cancer, the use of innovative therapies in gynecological malignancies, the technique of sentinel lymph node in gynecological malignancies especially in vulvar cancer, and the use of intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

View profile

Book chapters authored 1

Books edited 0

Introducing your Author Service Manager

Ms. Ana Cink

As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire